Family history of thyroid cancer and the risk of differentiated thyroid cancer in French Polynesia

Thyroid

Volumn 20, Issue 4, 2010, Pages 393-400

  Brindel, Pauline ^a,b,c   Doyon, Françoise ^a,b,c   Bourgain, Catherine ^c,d   Rachédi, Frédérique ^e   Boissin, Jean Louis ^f   Sebbag, Joseph ^g   Shan, Larrys ^h   Bost Bezeaud, Frédérique ^e   Petitdidier, Patrice ⁱ   Paoaafaite, John ^j   Teuri, Joseph ^j   De Vathaire, Florent ^a,b,c  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSERM   (France)

^e Territorial Hospital Mamao   (French Polynesia)

^f IPRAME   (French Polynesia)

^g Clinique Paofai   (French Polynesia)

^h Endocrinologist   (French Polynesia)

ⁱ Laboratory of Anatomy and Cytopathology Boz and Petitdidier   (French Polynesia)

^j UMR152   (French Polynesia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FAMILY HISTORY; FAMILY STUDY; FEMALE; FRENCH POLYNESIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID CANCER;

ADOLESCENT; ADULT; CHILD; FAMILY HEALTH; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NUCLEAR WARFARE; ODDS RATIO; POLYNESIA; REGRESSION ANALYSIS; THYROID NEOPLASMS;

EID: 77952407075     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0350     Document Type: Article

References (37)

1. de Vathaire F, Le Vu B, Vathaire CC 2000 Thyroid cancer in French Polynesia between 1985 and 1995: influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1966 and 1974. Cancer Causes Control 11:59-63.
2. Gleize L, Laudon F, Sun LY, Challeton-de Vathaire C, Le Vu B, de Vathaire F 2000 Cancer registry of French Polynesia: results for the 1990-1995 period among native and immigrant population. Eur J Epidemiol 16:661-667.
3. Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, Parshin V, Parshkov E, Piliptsevich N, Pinchera A, Polyakov S, Shabeka N, Suonio E, Tenet V, Tsyb A, Yamashita S, Williams D 2009 Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97:724-732.
4. De Vathaire F, Hardiman C, Shamsaldin A, Campbell S, Grimaud E, Hawkins M, Raquin M, Oberlin O, Diallo I, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Lemerle J, Chavaudra J, Schlumberger M, Bonäiti C 1999 Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med 159:2713-2719.
5. Lindberg S, Karlsson P, Arvidsson B, Holmberg E, Lunberg LM, Wallgren A 1995 Cancer incidence after radiotherapy for skin haemangioma during infancy. Acta Oncol 34:735-740.
6. Lundell M, Hakulinen T, Holm LE 1994 Thyroid cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 140:334-339.
7. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277.
8. Hemminki K, Vaittinen P, Kyyronen P 1998 Age-specific familial risks in common cancers of the offspring. Int J Cancer 78:172-175. (Pubitemid 28443173)
9. Hemminki K, Dong C 2000 Familial relationships in thyroid cancer by histo-pathological type. Int J Cancer 85:201-205.
10. Horn-Ross PL, Morris JS, Lee M, West DW, Whittemore AS, McDougall IR, Nowels K, Stewart SL, Spate VL, Shiau AC, Krone MR 2001 Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomark Prev 10:979-985. (Pubitemid 32844907)
11. Mack WJ, Preston-Martin S, Bernstein L, Qian D 2002 Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol 12:395-401.
12. Memon A, Berrington DG, Luqmani Y, Suresh A 2004 Family history of benign thyroid disease and cancer and risk of thyroid cancer. Eur J Cancer 40:754-760.
13. Ron E, Kleinerman RA, Boice JD, Jr., LiVolsi VA, Flannery JT, Fraumeni JF 1987 A population-based case-control study of thyroid cancer. J Natl Cancer Inst 79:1-12.
14. United Nations Scientific Committee on the Effects of Atomic R 2000 Sources and Effects of Ionizing Radiation. Report to the General Assembly with Annexes. New York: United Nations.
15. Brindel P, Doyon F, Rachedi F, Boissin JL, Sebbag J, Shan L, Chungue V, Bost-Bezeaud F, Petitdidier P, Paoaafaite J, Teuri J, de Vathaire F 2008 Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control 20:581-590.
16. Brindel P, Doyon F, Rachedi F, Boissin LJ, Sebbag J, Shan L, Chung V, Kai Sun LY, Bost-Bezeaud F, Petitdidier P, Morales P, Paoaafaite J, Teuri J, de Vathaire F 2008 Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol 167:219-229.
17. Perdu J, Boutouyrie P, Bourgain C, Stern N, Laloux B, Bozec E, Azizi M, Bonaiti-Pellié C, Plouin PF, Laurent S, Gimenez-Roqueplo AP, Jeunemaitre X 2007 Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens 21:393-400. (Pubitemid 46646173)
18. Kerber RA 1995 Method for calculating risk associated with family history of a disease. Genet Epidemiol 12:291-301.
19. Malecot G 1948. Les Mathématiques de l'Héré dité. Masson (ed), Paris.
20. Khoury MJ, Flanders WD 1995 Bias in using family history as a risk factor in case-control studies of disease. Epidemiology 6:511-519.
21. Ron E, Kleinerman RA, LiVolsi VA, Fraumeni JF 1991 Familial nonmedullary thyroid cancer. Oncology 48:309-311.
22. Hemminki K, Vaittinen P 1997 Effect of paternal and maternal cancer on cancer in the offspring: a population-based study. Cancer Epidemiol Biomark Prev 6:993-997.
23. Frich L, Glattre E, Akslen LA 2001 Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway. Cancer Epidemiol Biomark Prev 10:113-117.
24. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH 1994 Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608.
25. Galanti MR, Ekbom A, Grimelius L, Yuen J 1997 Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 75:451-456.
26. Pal T, Vogl FD, Chappuis PO, Tsang R, Brierley J, Renard H, Sanders K, Kantemiroff T, Bagha S, Goldgar DE, Narod SA, Foulkes WD 2001 Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86:5307-5312.
27. Hemminki K, Eng C, Chen B 2005 Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 90:5747-5753.
28. Lesueur F, Stark M, Tocco T, Ayadi H, Delisle MJ, Goldgar DE, Schlumberger M, Romeo G, Canzian F 1999 Genetic heterogeneityinfamilialnonmedullary thyroidcarcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 84:2157-2162.
29. Sturgeon C, Clark OH 2005 Familial nonmedullary thyroid cancer. Thyroid 15:588-593.
30. Nagy R, Sweet K, Eng C 2004 Highly penetrant hereditary cancer syndromes. Oncogene 23:6445-6670.
31. Adjadj E, Schlumberger M, de Vathaire F 2009 Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol 10:181-190.
32. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A 2008 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105:7269-7274.
33. Hernández A, Céspedes W, Xamena N, Surrallés J, Creus A, Galofré P, Marcos R 2003 Glutathione S-transferase polymorphisms in thyroid cancer patients. Cancer Lett 190:37-44.
34. Ho T, Zhao C, Zheng R, Liu Z, Wei Q, Sturgis EM 2008 Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis. Arch Otolaryngol Head Neck Surg 132:756-761.
35. Morari EC, Leite JL, Granja F, da Assumpcao LV, Ward LS 2002 The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol Biomark Prev 11:1485-1488.
36. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV, Ward LS 2004 Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett 210:151-157.
37. Rogounovitch TI, Saenko VA, Ashizawa K, Sedliarou IA, Namba H, Abrosimov AY, Lushnikov EF, Roumiantsev PO, Konova MV, Petoukhova NS, Tchebotareva IV, Ivanov VK, Chekin SY, Bogdanova TI, Tronko MD, Tsyb AF, Thomas GA, Yamashita S 2006 TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Oncol Rep 15:949-956.